Psychedelic-Assisted Therapy

Psychedelic-assisted therapy refers to the therapeutic use of psychedelic drugs such as LSD, psilocybin, DMT, mescaline, and MDMA under strict professional supervision. Clients are prepared in advance by the therapist and then helped afterward to integrate and understand their experience with the drug. In a psychedelic-assisted therapy session, the client is administered the drug and then, as the drug takes effect, guided by the therapist to explore their feelings and experience. Both client and therapist remain in session until the drug wears off completely. Follow-up sessions help the client fully integrate their experiences. We’ve started gathering valuable information on this topic, but haven’t yet curated the findings.

My Adventures with the Trip Doctors

My first psilocybin journey began around an altar in the middle of a second-story loft in a suburb of a small city on the Eastern Seaboard.

Psychedelics Could Trigger a ‘Paradigm Shift’ in Mental Health Care

A new review of studies finds that LSD, psilocybin, and MDMA hold potential for treating mental illness.

The Trip Treatment

Research into psychedelics, shut down for decades, is now yielding exciting results.

A Conversation with Albert Hofmann

On November 26, 1996, Charles Grob, M.D. visited with Albert Hofmann in Rheinfelden, outside of Basel, Switzerland, where Dr. Hofmann was recovering from knee surgery. The following are excerpts from their conversation.

The Struggle to Turn Psychedelics into Life-Changing Treatments

Scientist Robin Carhart-Harris wants to use psychedelic drugs to treat psychiatric disorders. Early results are promising—but can he convince big pharma and the public of their potential?

Dr. Robin Carhart-Harris Is the First Scientist in Over 40 Years to Test LSD on Humans—And You're Next

The scientist talks to Laurence Phelan about fighting the establishment, battling preconceptions and breaking down egos.

Interview with Albert Hofmann, the Man Who First Synthesized LSD

The late chemist Albert Hofmann discussed his psychedelic research on LSD in the July, 1976 issue of High Times.

Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials

Lysergic acid diethylamide (LSD) was studied from the 1950s to the 1970s to evaluate behavioral and personality changes, as well as remission of psychiatric symptoms in various disorders.


The information offered here is not a substitute for professional advice. Please proceed with care and caution.


Psychedelic Research